Single-use Bioreactors Market worth 1,085.7 M USD by 2021

Friday 7 October 2016, Amsterdam

The report, now available on ASDReports, "Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021", The single-use bioreactors market is projected to reach USD 1,085.7 Million by 2021 from USD 408.4 Million in 2016, growing at a CAGR of 21.6% during the forecast period of 2016 to 2021.

Improved returns on investment for small companies and startups, and reduced complexity of automation are the major factors driving the adoption of single-use bioreactors. On the other hand, regulatory concerns related to SUBs and issues regarding leachables and extractables are the major factors restraining the growth of this market.

The single-use bioreactors market is segmented on the basis of product type, cell type, technology, application, end user, and region. Based on product type, the market is segmented into monoclonal antibodies, vaccines, gene-modified cells, recombinant proteins, stem cells, and other products (growth factors, interferons, and antisense DNA & RNA). The monoclonal antibodies segment is expected to dominate this market primarily due to the rising demand for monoclonal antibodies in medical treatments owing to their high therapeutic efficiency.

On the basis of cell type, the single-use bioreactors market is categorized into mammalian cells, bacteria, yeast, and other cells (insect cells and plant cells). In 2016, the mammalian cells segment is expected to account for the largest share of the single-use bioreactors market owing to the increasing application of these cells in biologics manufacturing as a result of the highly mechanized metabolic machinery required for complex biomolecules.

Based on technology, the market is segmented into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors, and other technologies. The wave-induced motion SUBs segment is expected to account for the largest market share in 2016. Growth in this segment can be attributed to the advantages of wave-induced motion SUBs, such as high flexibility and shorter lead times.

The application segments in the single-use bioreactors market include bioproduction processes, process development, and research & development. The bioproduction processes segment is expected to account for the largest market share in 2016. Considering advantages such as low investments and easy implementation, single-use bioreactors are increasingly being adopted in bioproduction processes. This is the major factor responsible for the large share of this application segment.

The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech SA (France), Merck Millipore (Germany), GE Healthcare (U.K.), Danaher Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).